Search This Blog

Monday, March 1, 2021

GLAXOSMITHKLINE gets Buy rating from Goldman Sachs

In a research note published by Keyur Parekh, Goldman Sachs advises its customers to buy the stock. The target price is decreased from GBX 2010 to GBX 1820.

https://www.marketscreener.com/quote/stock/GLAXOSMITHKLINE-PLC-9590199/news/GLAXOSMITHKLINE-nbsp-Buy-rating-from-Goldman-Sachs-32575867/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.